Spending on nursing homes, home care slows year over year
By
Kathleen Steele Gaivin
Jun 27, 2024
Between May 2023 and May 2024, overall healthcare costs grew by 3.4%, the fastest increase seen since December 2007, according to Altarum’s monthly Health Sector Economic Indicators brief, released Wednesday.
Senior living affordability, workforce development at center of revamped SENIOR Act
By
Kimberly Bonvissuto
Mar 11, 2024
Workforce development and increased access to assisted living are the key provisions of an updated bipartisan bill backed by Argentum.
CMS announces Alzheimer’s drug coverage policy, but ‘the devil is in the details,’ experts say
By
Kimberly Bonvissuto
Jun 01, 2023
A Thursday announcement by the Centers for Medicare & Medicaid Services regarding coverage of Alzheimer’s drugs is being met with skepticism by some industry advocates who say that “the devil is in...
FDA approves Capvaxive pneumococcal 21-valent conjugate vaccine
Jun 21, 2024
Merck says the vaccine covers serotypes responsible for approximately 84% of invasive pneumococcal disease in adults aged 50 or more years.
Preventing abuse in guardianship focus of proposed bill, final rule
By
Kimberly Bonvissuto
May 09, 2024
Proposed legislation aims to reduce the potential for abuse of older adults and people with disabilities by creating public awareness about alternatives to guardianship, whereas a new federal final rule...
Acts Retirement-Life, Mease Life consider affiliation
By
Kathleen Steele Gaivin
Apr 06, 2023
Fort Washington, PA-based Acts Retirement–Life Communities and Mease Life of Dunedin, FL, have signed a letter of intent to explore a possible affiliation. A due diligence review has begun, and the companies...
Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.
FDA approves second OTC naloxone spray for suspected opioid overdose
Aug 03, 2023
The American Medical Association applauded the approval to improve access to nonprescription naloxone as a way to curb the opioid epidemic.
FDA approves new antibiotic for uncomplicated urinary tract tnfections
Apr 30, 2024
Approval of Pivya is for female adults with UTIs caused by susceptible isolates of E. coli, P. mirabilis,and S. saprophyticus.
Fight against joint employer rule sees ‘significant procedural win’
By
Lois A. Bowers
Jun 13, 2024
A plaintiff in a lawsuit against the National Labor Relations Board over its joint employer rule is calling a recent court ruling a “significant procedural win.”